Discovery of bioactive small molecule inhibitors of human PD1-PDL1 interaction

被引：0
|
作者：
Patil, S. P. [1 ]
Diflumeri, J. [1 ]
Fattakhova, E. [1 ]
机构：
[1] Widener Univ, Chem Engn, Chester, PA 19013 USA
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Machine-Learning Guided Discovery of Bioactive Inhibitors of PD1-PDL1 Interaction
    Patil, Sachin P.
    Fattakhova, Elena
    Hofer, Jeremy
    Oravic, Michael
    Bender, Autumn
    Brearey, Jason
    Parker, Daniel
    Radnoff, Madison
    Smith, Zackary
    PHARMACEUTICALS, 2022, 15 (05)
  • [2] Small molecules and macrocycles antagonizing human PD1-PDL1
    Doemling, Alexander
    Holak, Tad
    Shaabani, Shabnam
    Zarganis, Tryfon
    Magiera-Mularz, Katarzyna
    Zak, Krzysztof
    Dubin, Grzegorz
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [3] Macrocyclic Compounds from Ansamycin Antibiotic Class as Inhibitors of PD1-PDL1 Protein-Protein Interaction
    Patil, Sachin P.
    Yoon, Suk-Chung
    Aradhya, Abhay G.
    Hofer, Jeremy
    Fink, Madison A.
    Eney, Erika S.
    Fisher, James E.
    Herb, Marie C.
    Klingos, Anthony
    Proulx, James T.
    Fedorky, Megan T.
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2018, 66 (08) : 773 - 778
  • [4] ANALYSIS OF THE IMMUNE REGULATION VIA PD1-PDL1 IN MYELOFIBROSIS
    Botella Garcia, C.
    Garcia Gutierrez, V
    Garcia Cossio, M.
    Lopez Jimenez, J.
    HAEMATOLOGICA, 2017, 102 : 288 - 288
  • [5] PD1-PDL1 interaction as a superior predictor for response to immune checkpoint therapy in NSCLC patients
    Micke, Patrick
    Lindberg, Amanda
    Artursson, Rebecca
    Hellberg, Louise
    Yu, Hui
    Backman, Max
    Botling, Johan
    Brunnstrom, Hans
    Mezheyeuski, Artur
    Isaksson, Johan
    Strell, Carina
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Integrating in situ proximity ligation assay for PD1-PDL1 interaction with multiplexed immunofluorescence imaging
    Ullman, Tony
    Krantz, David
    Elofsson, Hampus
    Sepulveda, Carolina Oses
    Zieba-Wicher, Agata
    Ostling, Paivi
    Ullen, Anders
    Basu, Subham
    Stadler, Charlotte
    CANCER RESEARCH, 2024, 84 (06)
  • [7] Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy
    Zhang, Hongbo
    Xia, Yu
    Yu, Chunqiu
    Du, Huijie
    Liu, Jinchang
    Li, Hui
    Huang, Shihui
    Zhu, Qihua
    Xu, Yungen
    Zou, Yi
    MOLECULES, 2021, 26 (11): : 3347
  • [8] The Impact of the PD1-PDL1 Pathway in Breg-Induced Transplantation Tolerance
    Liao, M.
    Lee, K.
    Deng, K.
    Leguern, C.
    Markmann, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1070 - S1070
  • [9] Novel, small molecule inhibitors of PD-L1/PD-1 interaction.
    Sivanandhan, Dhanalakshmi
    Rajagopal, Sridharan
    Naveen, Sadhu M.
    Gajendran, Chandru
    Venkateshappa, Chandregowda
    Reddy, Muralidhar
    Kishore, Pendyala Satya
    Deshpande, Pratima
    Kannan, Sundarajan
    Sahareen, Tabassum
    Viswakarma, Santhosh
    Siddiqui, Amir
    Zainuddin, Mohammed
    Rudresh, G.
    Daram, Prashanthi
    Gosu, Ramchandraiah
    Devi, Rashmi Rekha
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Predicting a Stable Dimeric Form of the PD1-PDL1 Complex: Implications for Understanding the PD1 Activation Mechanism
    Ponce, Luis F.
    Ramirez-Echemendia, Daniel P.
    Leon, Kalet
    Valiente, Pedro A.
    JOURNAL OF PHYSICAL CHEMISTRY B, 2023, 127 (26): : 5764 - 5771
12345